Kromek Share Price (KMK)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Kromek	LSE:KMK	London	Ordinary Share	GB00BD7V5D43	ORD 1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-0.05p	-0.20%	24.50p	26,121	08:02:58

Bid Price		Offer Price	High Price	Low Price	Open Price
24.00p		25.00p	24.55p	24.50p	24.55p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	11.85	-2.53	-0.40		84.4

Related Shares
AstraZeneca (AZN), GlaxoSmithKline (GSK), Venn Life (VENN), Port Erin (PEBI)

Kromek (KMK) Latest News

Kromek News

Date	Time	Source	Headline
29/3/2019	16:51	UKREG	Kromek Group PLC Change of Adviser
18/3/2019	17:50	UKREG	Kromek Group PLC Director Dealings Correction
28/2/2019	13:00	UKREG	Kromek Group PLC Holding(s) in Company
28/2/2019	13:00	UKREG	Kromek Group PLC Holding(s) in Company
28/2/2019	12:55	UKREG	Kromek Group PLC Holding(s) in Company
28/2/2019	12:55	UKREG	Kromek Group PLC Holding(s) in Company
28/2/2019	12:50	UKREG	Kromek Group PLC Holding(s) in Company
26/2/2019	12:56	UKREG	Kromek Group PLC Director Dealings
26/2/2019	10:16	ALNC	Kromek Signs New USD1.4 Million Multi-Year Nuclear Security Deal
26/2/2019	07:58	ALNCF	Alliance News Flash Headline

More Kromek News

Kromek Takeover Rumours

Kromek (KMK) Share Charts

1 Year Kromek Chart

1 Month Kromek Chart

Intraday Kromek Chart

Kromek (KMK) Discussions and Chat

Kromek Forums and Chat

Date	Time	Title	Posts
08/4/2019	07:12	Kromek Group PLC	2,663
21/8/2017	10:01	Kromek Group (KMK) - Overvalued AIM mugging	181

Add a New Thread

Kromek (KMK) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Kromek trades in real-time

Kromek (KMK) Top Chat Posts

Date	Subject
19/4/2019 09:20	Kromek Daily Update: Kromek is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 24.55p. Kromek has a 4 week average price of 24p and a 12 week average price of 24p. The 1 year high share price is 31.65p while the 1 year low share price is currently 21.20p. There are currently 344,559,089 shares in issue and the average daily traded volume is 273,366 shares. The market capitalisation of Kromek is £84,416,976.81. Read Full Thread Reply
07/3/2019 08:32	quepassa: 25p on the bid this morning. As more Placing Stags realise that they are facing the increasingly stark possibility of losing money on the 25p Placing Price, this share price is likely in my view to fall further in the coming days. ALL IMO. DYOR. QP Read Full Thread Follow Reply
28/1/2019 09:57	culford: Better late than never! The big orders are starting. This one is worth $58m over 7 years, or ££6m p.a. recurring. As that is 50% of last years sales and more than 33% of current year forecast sales it is very significant. Put another way, at a 50% margin, this is £21m over next 7 years or about 1/3 current share price. There will be more such orders and KMK is only at the beginning of the CZT replacement cycle in medical imaging. The concern as raised on here is the balance sheet. Company moved manufacturing facilities during the year which disrupted production from May to December. It is now working double shifts to recover lost time and it will be important to see debtors turned back into cash now that they are shipping again (under long term contracts stock is classified as debtors). Read Full Thread Follow Reply
17/1/2019 15:56	quepassa: Hi Culford, You seem like a decent enough sort of chap but aren't you completely deluding yourself about Kromek? For example this is what you wrote two years ago in post number 685 on 21/12/16 :- "Isa This one has huge potential but may be 12 months from take off. The big contracts are scheduled for back end of 2017." So where are these "big contracts"???? and your post 690 of 22/12/16:- "QP KMK has disappointed the markets and its share price is languishing accordingly. In year to April 13 its revenues were Â£2.7m and in year to April 16 its revenues were Â£8.3m - a growth of threefold over three years. In the last year, when it attracted Sir Peter Williams to become its Chairman, its orders received were $30m, or cÂ£24m, but these will be received over multiple years. In the current year, sales will be marginally higher at cÂ£9m. In the past year it has become sole supplier to Darpa, the US agency to which it has supplied >$6m of sales. Darpa has said that it will increase the size of its nuclear detection tests (which need KMK's devices) in 2017 before rolling this out to c15 US cities in 2018. See last news: http://www.darpa.mil/news-events/2016-10-11 KMK will receive orders of c$10m for each city so that is orders of c$150m to be received from end of 2017 for 2018 and beyond. In October it received orders for a military solution for the US and UK military, which will be of similar scale and slightly later timing. Thus whilst i share your disappointment on the share performance, you cannot say that there is a diminutive growth in sales and the potential growth can be checked from third party sources." ...and there are numerous other similar examples from you. All these posts of yours have been proved time and time again to be nothing other than pie-in-the-sky. $150million of orders?????????????? Come on, that is just plain nonsense and has been proved as such. No offense intended but isn't now the time for you to face up to reality, remove the rose coloured glasses and stop the hype ?? ALL IMO. DYOR. QP Read Full Thread Follow Reply
17/1/2019 12:10	culford: This company has market leading IP in two huge markets (medical screening and nuclear detection). Its IP has been validated by the US and UK governments and a lot of commercial customers now. It is a matter of time before it makes the break through with large orders and a commensurate increase in share price/valuation. In meantime revenues from smaller customers is growing at >20% p.a. and it became EBITDA positive last year. Not sure why it upsets Chimers so? Read Full Thread Follow Reply
09/1/2019 20:09	cerrito: For the record this appeared in today's Telegraph Questor quote We tipped Kromek, which makes advanced radiological detectors, in March 2017, also on the basis of Gervais Williams’s holding of the stock. Its share price is now 1.9pc lower but the fund manager has lost none of his faith in the business. “So far it has not had the big break we are looking for but we think it has the potential to become a very substantial business,” he said. “We have not sold any shares – in fact we have bought more.” Hold. Questor says: hold Ticker: KMK Read Full Thread Follow Reply
03/1/2019 11:29	quepassa: YAWN YAWN YAWN "although I know nothing about charting , the share price graph has been moving up for some while " that is a false and misleading statement. 80p five years ago and 26p today. Read Full Thread Follow Reply
03/1/2019 11:03	mrnumpty: Que passa . Of course the share price has fallen from 80 p . It has since reached 20 p twice ( autumn 2016 and spring 2018 ) . During that drop , every time the price rose , it was followed by a long , lingering fall , always reaching a new low . Since this spring , the price has been recovering , with a reversal of the graph ( a gradual rise , followed by a drop , but generally rising ) . This reversal surely reflect the fact that Kromek is no longer based on mere hope , and that it is starting to make sales . I had the honesty and humility to openly admit that I know nothing about charting . I am astonished by your claim that I had made a " false and misleading claim " : nothing could be further from the truth , as I detest ramping, whether attempting to nanipualate prices up or down . I had thought that , apart from the ubiquitous " chimera " , this chat site for Kromek was only used by investors for an honest exchange of information and opinions . I cannot be bothered to become embroiled in one of the vile exchanges which blight the internet , so I shall not bother to post here . I repeat : I made it blatantly clear that what I wrote was my OPINION , and that I am not an expert on charting . Read Full Thread Follow Reply
02/1/2019 16:35	mrnumpty: In today's article , Simon Thomson of the Investors' Chronicle targets a share price of 37p , thus a 40% increase on the price when he released his article ( 26.5p ) . Having subscribed to the IC for a few years , it seems clear to me that Simon Thomson is not given to wild excitement , but proceeds instead in small increments . However , and this is pure speculation on my part , but I feel that this is a very unadventurous target . As Simon Thomson writes , Kromek's products seem to be gaining traction , so the Company should soon move out of the most dangerous phase of its existence , when it has been loss-making . Having invested for over twenty years , Kromek reminds me of other small , niche companies in technology which have eventually gone on to great things . Such companies , which I sold far too early , include " Gooch and Housego " and " XP Power " . Before getting to such a stage , there is a huge amount of what Simon Thomson calls " execution risk " , which translates as " there's many a slip between cup and lip " . Furthermore , although I know nothing about charting , the share price graph has been moving up for some while . Personally , I intend to hold for a long time , by which time I think that the price will be far higher than 40p . Nevertheless , all of the above is only my opinion , so DO YOUR OWN RESEARCH . Good luck with all your investments . Read Full Thread Follow Reply
15/11/2017 16:01	glawsiain: Heres the text from telegraph for what its worth: "On the face of it, our suggestion that readers buy shares in Kromek, the Aim-listed maker of advanced detection equipment, has not gone well. We first tipped the shares at 27p in March, and reiterated the advice at 29.75p in May, and at 26.63p the following month. At 23.25p last night, readers who took our advice are sitting on paper losses of 13.9pc, 21.8pc and 12.7pc respectively. But this is a case where it looks as though the market may have got it wrong – something that is more likely in the case of a small stock such as Kromek. Various factors can cause the market to misprice a small business, ranging from technical devices such as stop-losses to simple impatience on the part of investors. Gervais Williams, a respected investor in smaller companies, who holds Kromek in his Miton UK Smaller Companies fund, said that because there hadn’t been much upward momentum in the share price, even a small amount of trading in the stock could move the price. “To some degree this can be self-fulfilling in the short term,” he said, pointing out that some recent falls “will have triggered a few stop-loss limits for some small holders”, leading to more selling. He said disposals by another fund management firm might also have been a cause of recent weakness. Williams added: “The key fundamental is that we are all excited about the potential orders for Kromek’s products, and if these announcements take a while to arrive then the market gets a bit bored. The lack of momentum does leave the share price at risk after a short-term spike. "I suspect we will see an institutional investor stepping in at some stage to see if there is any real volume of stock about. I don’t think there is, and after a few days, all things being equal, I assume the price will revert to where it was previously.” Currently the shares are flirting with record lows close to 20p. If Williams is right about the trading dynamics, we can perhaps expect them to return closer to 30p – which would of course represent a substantial increase. Ultimately, though, Questor is more interested in companies that have good products and can sell them profitably than in the day-to-day moods of the stock market. In this respect, Williams is unworried. “Am I holding? You bet,” he said. “In terms of conviction in the company I’m not the least bit bothered.” Readers can also take some reassurance from the fact that there has been some small-scale buying by Kromek’s directors at the depressed share prices of recent weeks. Questor says: buy Ticker: KMK Share price at close: 23.25p" Read Full Thread Follow Reply
12/4/2017 07:34	hyperboreus: Not wishing to comment on anything that has gone before but ST did in fact reply yesterday to patient_investor regarding Kromek in his comments section basically just reiterating his current stance on the Company: 1:17 PM on 11/4/2017 Hi Simon, Please could you provide your thoughts on KMK share price returning to 26.40p, a fall of some 30% since their inevitable spike in the aftermath of your tip? Do you still rate the shares a "strong buy"? Regards Patient SIMONTHOMPSON 1:36 PM on 11/4/2017 Patient I advised buying Kromek shares at 25p on Monday, 27 February after which almost 12 million shares traded in 689 bargains in the following two days. The weight of money continued to chase the shares and this meant that the share price moved up 36 per cent from 25.5p on the offer at 12pm on Monday 27 February to a high of 34.9p on Tuesday 7 March. In my analysis I stated that: "From my lens, the bottom is now in place and a break-out above the 25p resistance is highly likely, suggesting a sharp move to the 30p resistance level that halted progress last summer. Beyond that analyst's 34p a share price targets come firmly into play." I can't blame anyone for taking a 36 per cent profit in the space of a week. I would also mention that the Daily Telegraph subsequently tipped the shares which accentuated the rise and a fair amount of that buying was hot money, hence the subsequent fall. Nothing has changed in terms of the investment case as I still believe that 34p a share is fair value. I would flag up that subsequent to my article, on 24 March 2017, Berry Beumer, Chief Operating Officer of Kromek, purchased 80,000 Ordinary Shares at a price of 29.35 pence per share. Also, Kromek has also been awarded a contract, valued at $990k, by an existing US-based customer, a global leader in aerospace and defence technologies, for the upgrade of the Company's advanced security screening detectors that the customer has deployed since 2009. I believe the shares rate a buy at 26p. I hope this clarifies matters. Best wishes Read Full Thread Follow Reply

Kromek share price data is direct from the London Stock Exchange

Your Recent History

LSE

KMK

Kromek

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190420 05:15:37